Adipokines as Potential Biomarkers in Pregnancy: A Naturalistic Study of Adipokines in Pregnant Women and Newborns
Biomolecules · 2025
DOI: 10.3390/biom15050607 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Cristina Mihaela Ormindean und 12 weiteren Autor:innen. Beteiligte Einrichtung: 2nd Department of Obstetrics and Gynaecology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: Adipokines, Pregnancy Complications. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Maternal obesity is an escalating public health concern that adversely affects pregnancy outcomes. Adipokines play a key role in regulating metabolism and fetal development, but their dynamic changes during pregnancy remain inadequately understood.
Objective
This study investigates maternal and fetal adipokine variations throughout pregnancy and their associations with maternal body mass index (BMI), abdominal wall thickness, and neonatal outcomes.
Methods
A prospective case-control study was conducted involving 74 pregnant women categorized by BMI. Maternal blood samples were collected at mid-pregnancy and delivery, and additional analysis of umbilical-cord blood was performed. Clinical parameters such as BMI, abdominal wall thickness, and fetal growth metrics were also recorded.
Results
Adiponectin levels were significantly lower in obese pregnancies, whereas leptin and visfatin levels increased with higher maternal BMI. Umbilical-cord blood leptin levels correlated positively with maternal BMI and neonatal birth weight, while ghrelin levels were reduced in neonates born to obese mothers. Significant adipokine fluctuations were observed between mid-pregnancy and delivery.
Conclusions
Maternal obesity is associated with distinct alterations in adipokine profiles. These findings highlight the potential of maternal adipokines, given their links to maternal adiposity, as predictive biomarkers for adverse pregnancy outcomes and long-term metabolic risks in offspring. Further interventional research is warranted to evaluate targeted strategies aimed at improving perinatal metabolic health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 2nd Department of Obstetrics and Gynaecology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
ORCID-Profile: Cristina Mihaela Ormindean, Andrei Mihai Măluțan, Carmen Elena Bucuri, Maria Patricia Roman, Ionel Daniel Nati, Viorela Suciu
Zitieren
APA
Ormindean, C. M., Ciortea, R., Măluțan, A. M., Bucuri, C. E., Diculescu, D. M., Iuhas, C. I., Porumb, C. G., Ormindean, V., Roman, M. P., Nati, I. D., Suciu, V., Hăprean, A. E., & Mihu, D. (2025). Adipokines as Potential Biomarkers in Pregnancy: A Naturalistic Study of Adipokines in Pregnant Women and Newborns. Biomolecules. https://doi.org/10.3390/biom15050607
Vancouver
Ormindean CM, Ciortea R, Măluțan AM, Bucuri CE, Diculescu DM, Iuhas CI, et al. Adipokines as Potential Biomarkers in Pregnancy: A Naturalistic Study of Adipokines in Pregnant Women and Newborns. Biomolecules. 2025. doi:10.3390/biom15050607
BibTeX
@article{Ormindean2025,
author = {Ormindean, Cristina Mihaela and Ciortea, Răzvan and Măluțan, Andrei Mihai and Bucuri, Carmen Elena and Diculescu, Doru Mihai and Iuhas, Cristian Ioan and Porumb, Ciprian Gheorghe and Ormindean, Vlad and Roman, Maria Patricia and Nati, Ionel Daniel and Suciu, Viorela and Hăprean, Alexandru Emil and Mihu, Dan},
title = {Adipokines as Potential Biomarkers in Pregnancy: A Naturalistic Study of Adipokines in Pregnant Women and Newborns},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15050607}
}
EUVIMED